KASL clinical practice guidelines for management of chronic hepatitis B
Clin Mol Hepatol. 2019;25(2):93-159. Published online 2019 Jun 12 DOI: https://doi.org/10.3350/cmh.2019.1002
|
Citations to this article as recorded by
Hepatitis B Virus DNA-Level Change is Associated With Tumor Recurrence in Patients With Resected Hepatitis B Virus Hepatocellular Carcinoma
Won Tae Cho, Tae Yoo, Jung Min Lee, Jung Woo Lee, Hanbaro Kim, Ji Soo Lee, Sang Hyup Han
Journal of Surgical Research.2024; 295: 231. CrossRef The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis
Log Young Kim, Jeong-Ju Yoo, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Dong Hyeon Lee, Jae Young Jang
Journal of Korean Medical Science.2024;[Epub] CrossRef Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines
Malgorzata Mikulska, Chiara Oltolini, Emanuela Zappulo, Michele Bartoletti, Anna Maria Frustaci, Andrea Visentin, Candida Vitale, Francesca R. Mauro
Blood Reviews.2024; 65: 101180. CrossRef Air pollution as a potential risk factor for hepatocellular carcinoma in Taiwanese patients after adjusting for chronic viral hepatitis
Tyng-Yuan Jang, Chi-Chang Ho, Chih-Da Wu, Chia-Yen Dai, Pau-Chung Chen
Journal of the Chinese Medical Association.2024; 87(3): 287. CrossRef Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy
Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, Sang Hoon Ahn, Won Kim, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Sun Young Yim, Jin Kyung Park, Soon
Cancers.2024; 16(5): 887. CrossRef Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels
Soon Kyu Lee, Soon Woo Nam, Jeong Won Jang, Jung Hyun Kwon
Diagnostics.2024; 14(5): 495. CrossRef Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study
Tyng‐Yuan Jang, Po‐Cheng Liang, Dae Won Jun, Jang Han Jung, Hidenori Toyoda, Chih‐Wen Wang, Man‐Fung Yuen, Ka Shing Cheung, Satoshi Yasuda, Sung Eun Kim, Eileen L Yoon, Jihyun An, Masaru Enomoto, Ritsuzo Kozuka, Makoto Chuma, Akito Nozaki, Toru Ishikawa,
Journal of Gastroenterology and Hepatology.2024; 39(6): 1190. CrossRef Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
Tae Hyung Kim, Ji Hoon Kim, Hyung Joon Yim, Yeon Seok Seo, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
Gut and Liver.2024; 18(2): 305. CrossRef Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
Heechul Nam, Ji Won Han, Soon Kyu Lee, Hyun Yang, Hae Lim Lee, Pil Soo Sung, Myeong Jun Song, Jung Hyun Kwon, Jeong Won Jang, U‐Im Chang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jin Mo Yang, Hee Yeon Kim
Journal of Gastroenterology and Hepatology.2024; 39(8): 1673. CrossRef How Does Chronic Hepatitis B Infection Impact on Severity of COVID-19 Infection?
Behnaz Khodabakhshi, Mahdi Mazandarani, Narges Lashkarbolouk, Mehrnaz Razzazan, Khadije Amjadi
International Journal of Infection.2024;[Epub] CrossRef Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang
PLOS ONE.2024; 19(8): e0307712. CrossRef Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Receiving Immunosuppressive Treatment: A Prospective Study
Nicoleta Mihai, Mihaela Cristina Olariu, Oana-Alexandra Ganea, Aida-Isabela Adamescu, Violeta Molagic, Ștefan Sorin Aramă, Cătălin Tilișcan, Victoria Aramă
Journal of Clinical Medicine.2024; 13(20): 6032. CrossRef Baseline and on‐treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals
Soo Young Hwang, Sung Hwan Yoo, Hye Young Chang, Sora Kim, Jung Il Lee, Kwan Sik Lee, Young Youn Cho, Kim Hyung Joon, Hyun Woong Lee
Journal of Viral Hepatitis.2023; 30(1): 39. CrossRef Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
Han Ah Lee, Seung Up Kim, Yeon Seok Seo, Sang Hoon Ahn, Chai Hong Rim
Hepatology Communications.2023; 7(2): e0011. CrossRef The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA
Han Ah Lee, Young‐Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Yeon Seok Seo, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(5): 716. CrossRef Low Level of Hepatitis B Viremia Compared With Undetectable Viremia Increases the Risk of Hepatocellular Carcinoma in Patients With Untreated Compensated Cirrhosis
Jiwon Yang, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
American Journal of Gastroenterology.2023; 118(6): 1010. CrossRef Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea–Japan collaborative study with 9200 patients
Woo‐Hyoung Kang, Shin Hwang, Masaki Kaibori, Jong Man Kim, Kyung Sik Kim, Tsuyoshi Kobayashi, Hiroto Kayashima, Yang Seok Koh, Keiichi Kubota, Akira Mori, Yutaka Takeda, Sung Su Yun, Kousuke Matsui, Kan Toriguchi, Hiroaki Nagano, Myung Hee Yoon, Yuji Soej
Journal of Hepato-Biliary-Pancreatic Sciences.2023; 30(8): 993. CrossRef Long-term outcomes of liver transplantation using grafts from donors with active hepatitis B virus replication: a multicenter cohort study
Sujin Gang, YoungRok Choi, Boram Lee, Kyung Chul Yoon, Su young Hong, Sanggyun Suh, Eui Soo Han, Suk Kyun Hong, Hae Won Lee, Jai Young Cho, Nam-joon Yi, Kwang-Woong Lee, Kyung-Suk Suh
Annals of Surgical Treatment and Research.2023; 104(4): 183. CrossRef Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Clinical and Molecular Hepatology.2023; 29(2): 367. CrossRef Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2023; 58(1): 99. CrossRef Research Progress on the Need for Antiviral Therapy in Chronic HBV Infected Patients with Normal ALT
益帆 胡
Advances in Clinical Medicine.2023; 13(04): 5360. CrossRef Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Nikolaos Pyrsopoulos, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(8): 1372. CrossRef Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B
Joo Hyun Oh, Yewan Park, Myung Ji Goh, Dong Hyun Sinn, Sang Bong Ahn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik
Scientific Reports.2023;[Epub] CrossRef Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
Beom Kyung Kim, Sang Hoon Ahn
Journal of the Formosan Medical Association.2023; 122(12): 1238. CrossRef Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?
Jonggi Choi, Won-Mook Choi, Young-Suk Lim
Clinics in Liver Disease.2023; 27(4): 809. CrossRef Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
Yewan Park, Danbee Kang, Dong Hyun Sinn, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
World Journal of Gastroenterology.2023; 29(24): 3843. CrossRef KASL clinical practice guidelines for management of autoimmune hepatitis 2022
Clinical and Molecular Hepatology.2023; 29(3): 542. CrossRef A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
Liver International.2023; 43(8): 1813. CrossRef Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
Clinical and Molecular Hepatology.2023; 29(3): 794. CrossRef Five‐year on‐treatment variables‐based PPACS model predicts subsequent hepatocellular carcinoma in entecavir/tenofovir‐treated patients
Yeonjung Ha, Jihye Lim, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Seong Gyu Hwang, Seungbong Han, Han Chu Lee
International Journal of Cancer.2023; 153(12): 2045. CrossRef The Effect of Entecavir and Tenofovir Disoproxil on Bone Mineral Density in Chronic Hepatitis B Treatment
Yasemin EMÜR GÜNAY, Arif Mansur COŞAR
Journal of Contemporary Medicine.2023; 13(5): 1013. CrossRef Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea
Yuri Cho, SeongBeom Park, SeonYoung Park, WonJung Choi, Book Kim, Helin Han
Infectious Diseases and Therapy.2023; 12(10): 2387. CrossRef Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
Soo Ryang Kim, Soo Ki Kim
Diagnostics.2023; 13(20): 3212. CrossRef Pretreatment gamma‐glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs
Tyng‐Yuan Jang, Po‐Cheng Liang, Dae Won Jun, Jang Han Jung, Hidenori Toyoda, Chih‐Wen Wang, Man‐Fung Yuen, Ka Shing Cheung, Satoshi Yasuda, Sung Eun Kim, Eileen L. Yoon, Jihyun An, Masaru Enomoto, Ritsuzo Kozuka, Makoto Chuma, Akito Nozaki, Toru Ishikawa,
The Kaohsiung Journal of Medical Sciences.2023;[Epub] CrossRef Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis
Cesar Henriquez-Camacho, Ana Isabel Hijas-Gomez, Carlos Risco Risco, Maria Angeles Ruiz Lapuente, Rosa Escudero-Sanchez, Victor Moreno Cuerda
Viruses.2023; 15(11): 2241. CrossRef A MicroRNA-Based Method for High-Viremia Detection—A New Approach on a Romanian Lot of Chronically Infected Patients with Hepatitis B Virus
Marina Manea, Dimitri Apostol, Ileana Constantinescu
Diagnostics.2023; 13(22): 3425. CrossRef Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance
Saein Kim, Sunghwan Yoo, Jung Il Lee, Sora Kim, Hye Young Chang, Dokyun Kim, Seok Hoon Jeong, Kwan Sik Lee, Hyun Woong Lee
Digestive Diseases and Sciences.2022; 67(1): 321. CrossRef Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B
Chan-Young Jung, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Clinical Gastroenterology and Hepatology.2022; 20(4): 956. CrossRef Long‐term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B
Young Eun Chon, Seung Up Kim, Yeon Seok Seo, Hye Won Lee, Han Ah Lee, Mi Na Kim, Yun Ho Roh, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Soo Young Park, Beom Kyung Kim
Journal of Gastroenterology and Hepatology.2022; 37(1): 200. CrossRef Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B
Myung Ji Goh, Wonseok Kang, Kwang Min Kim, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scandinavian Journal of Gastroenterology.2022; 57(1): 70. CrossRef Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection
Zhenyu Zhong, Weiting Liao, Lingyu Dai, Xiaojie Feng, Guannan Su, Yu Gao, Qiuying Wu, Peizeng Yang
Annals of the Rheumatic Diseases.2022; 81(4): 584. CrossRef Clinical Outcomes of Hepatitis B Virus–Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels
Jong-In Chang, Dong Hyun Sinn, Hyun Cho, Seonwoo Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Digestive Diseases and Sciences.2022; 67(9): 4565. CrossRef Comprehensive characterization of viral integrations and genomic aberrations in HBV‐infected intrahepatic cholangiocarcinomas
Jihyun An, Deokhoon Kim, Bora Oh, Yoo‐Jin Oh, Jihyun Song, Naomi Park, Ha Il Kim, Hyo Jeong Kang, Ji‐Hye Oh, Wonkyung Kim, Eunjung Lee, Chang Ohk Sung, Gi‐Won Song, Dae‐Ghon Kim, Eunsil Yu, Eric Letouzé, Jessica Zucman‐Rossi, Han Chu Lee, Ju Hyun Shim
Hepatology.2022; 75(4): 997. CrossRef Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patients
Hyung Joon Yim, Won Kim, Sang Hoon Ahn, Young Kul Jung, Soon Ho Um, Joo Hyun Sohn, Jae Young Jang, Dong Joon Kim, Eun‐Sook Park, So‐Young Jin, Kyun‐Hwan Kim
Journal of Gastroenterology and Hepatology.2022; 37(2): 378. CrossRef On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients
Chung‐Feng Huang, Tyng‐Yuan Jang, Dae Won Jun, Sang Bong Ahn, Jihyun An, Masaru Enomoto, Hirokazu Takahashi, Eiichi Ogawa, Eileen Yoon, Soung Won Jeong, Jae‐Jun Shim, Jae Yoon Jeong, Sung Eun Kim, Hyunwoo Oh, Hyoung Su Kim, Yong Kyun Cho, Ritsuzo Kozuka,
Liver International.2022; 42(1): 59. CrossRef Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B
Ho Soo Chun, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Digestive Diseases and Sciences.2022; 67(7): 3412. CrossRef Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels: a nationwide cohort study
Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
BMC Medicine.2022;[Epub] CrossRef Identification and Characterization of Besifovir-Resistant Hepatitis B Virus Isolated from a Chronic Hepatitis B Patient
Jong Chul Kim, Hye Young Lee, Ah Ram Lee, Mehrangiz Dezhbord, Da Rae Lee, Seong Ho Kim, Juhee Won, Soree Park, Na Yeon Kim, Jae Jin Shin, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo, Kyun-Hwan Kim
Biomedicines.2022; 10(2): 282. CrossRef Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries
Ben Kang, Dae Yong Yi, Byung-Ho Choe
Frontiers in Pediatrics.2022;[Epub] CrossRef Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data
Young‐Suk Lim, Wai‐Kay Seto, Masayuki Kurosaki, Scott Fung, Jia‐Horng Kao, Jinlin Hou, Stuart C. Gordon, John F. Flaherty, Leland J. Yee, Yang Zhao, Kosh Agarwal, Pietro Lampertico
Alimentary Pharmacology & Therapeutics.2022; 55(8): 921. CrossRef Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study
Young Eun Chon, Soo Young Park, Seung Up Kim, Han Pyo Hong, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Viral Hepatitis.2022; 29(4): 289. CrossRef Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B
Chan‐Young Jung, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Liver International.2022; 42(5): 1017. CrossRef Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis
Heejoon Jang, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Joon Yeul Nam, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon
Hepatology.2022; 76(2): 492. CrossRef Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis
Na Ryung Choi, Ju Yeon Kim, Ji Hoon Hong, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jihye Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
BMC Gastroenterology.2022;[Epub] CrossRef A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study
Yong Zhao, Ling Xiang Kong, Feng Shi Feng, Jiayin Yang, Guo Wei
BMC Cancer.2022;[Epub] CrossRef A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance
Hyun Yang, Si Hyun Bae, Heechul Nam, Hae Lim Lee, Sung Won Lee, Sun Hong Yoo, Myeong Jun Song, Jung Hyun Kwon, Soon Woo Nam, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
Journal of Hepatology.2022; 77(3): 632. CrossRef Definition and Management of the Immune Tolerance Phase in Chronic Hepatitis B
Young Mi Hong, Ki Tae Yoon
The Korean Journal of Gastroenterology.2022; 79(4): 156. CrossRef Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis
Young‐Suk Lim, Sang Hoon Ahn, Jae‐Jun Shim, Homie Razavi, Devin Razavi‐Shearer, Dong Hyun Sinn
Alimentary Pharmacology & Therapeutics.2022; 56(3): 519. CrossRef Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Seungbong Han, Young-Suk Lim
Journal of Clinical Investigation.2022;[Epub] CrossRef Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study
Jihye Lim, Jung‐Bok Lee, Jihyun An, Gi‐Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
Journal of Viral Hepatitis.2022; 29(9): 756. CrossRef Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir
Juhee Won, Ah Ram Lee, Mehrangiz Dezhbord, Da Rae Lee, Seong Ho Kim, Jong Chul Kim, Soree Park, Nayeon Kim, Byengjune Jae, Kyun-Hwan Kim
Biomedicines.2022; 10(7): 1637. CrossRef Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
European Journal of Internal Medicine.2022; 103: 122. CrossRef Study on the Retreatment, Outcome, and Potential Predictors of Recurrence in Patients With Recurrence of Hepatitis B After Functional Cure
Xiao Lin, Aixin Song, Junfeng Lu, Sujun Zheng, Zhongjie Hu, Lina Ma, Zhenhuan Cao, Hong Li, Yanhong Zheng, Shan Ren, Xinyue Chen
Frontiers in Immunology.2022;[Epub] CrossRef Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim
Clinical and Molecular Hepatology.2022; 28(3): 425. CrossRef The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
Jung Hwan Yu, Soon Gu Cho, Young-Joo Jin, Jin-Woo Lee
Clinical and Molecular Hepatology.2022; 28(3): 351. CrossRef Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease
Han Ah Lee, Seung-seob Kim, Jin-Young Choi, Yeon Seok Seo, Beom Jin Park, Ki Choon Sim, Seung Up Kim
Abdominal Radiology.2022; 47(11): 3733. CrossRef Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment
Soo Min Ahn, Jonggi Choi, Byong Duk Ye, Suk-Kyun Yang, Ji Seon Oh, Yong‑Gil Kim, Chang-Keun Lee, Bin Yoo, Sang Hyoung Park, Seokchan Hong
Gut and Liver.2022; 16(4): 567. CrossRef Correlation between hepatic venous pressure gradient and portal venous pressure gradient in hepatitis B cirrhosis with different hepatic veins anatomy
Yifan Lv, Qingkun Song, Zhendong Yue, Hongwei Zhao, Lei Wang, Zhenhua Fan, Yifan Wu, Mingming Meng, Ke Zhang, Li Jiang, Huiguo Ding, Yuening Zhang, Fuquan Liu
European Journal of Radiology.2022; 155: 110463. CrossRef Viral Hepatitis in Patients with Inflammatory Bowel Disease
Seung Hwan Shin, Sang Hyoung Park
The Korean Journal of Gastroenterology.2022; 80(2): 51. CrossRef Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
Ji Hun Lee, Seung Kak Shin, Seong Hee Kang, Tae Hyung Kim, Hyung Joon Yim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Oh Sang Kwon, Soon Ho Um, Kwan Soo Byun
Journal of Clinical Medicine.2022; 11(22): 6613. CrossRef Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
Xiao Lin, Yanhong Zheng, Hong Li, Junfeng Lu, Shan Ren, Yisi Liu, Xiaoxiao Wang, Sujun Zheng, Lina Ma, Zhenhuan Cao, Xinyue Chen
Frontiers in Immunology.2022;[Epub] CrossRef Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
Hyung Joon Yim, Ji Hoon Kim, Yong Kyun Cho, Young Oh Kweon, Hyun Chin Cho, Jae Seok Hwang, Changhyeong Lee, Moon Soo Koh, Yang-Hyun Baek, Young-Min Park, Jeong-Hoon Lee, Seung Up Kim, Min-Kyu Kang, Neung Hwa Park, June Sung Lee, Young Eun Chon, Gab Jin Ch
Drug Design, Development and Therapy.2022; Volume 16: 3263. CrossRef Chronic Hepatitis B Viral Activity Enough to Take Antiviral Drug Could Predict the Survival Rate in Malignant Lymphoma
Kwang-Il Seo, Jae-Cheol Jo, Da-Jung Kim, Jee-Yeong Jeong, Sangjin Lee, Ho-Sup Lee
Viruses.2022; 14(9): 1943. CrossRef Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B
Chan‐Young Jung, Hyung Woo Kim, Jung Il Lee, Hyun Woong Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Liver International.2022; 42(11): 2408. CrossRef Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis
Joo Hyun Oh, Dong Ah Park, Min Jung Ko, Jeong-Ju Yoo, Sun Young Yim, Ji-Hyun Ahn, Dae Won Jun, Sang Bong Ahn
Journal of Personalized Medicine.2022; 12(12): 1957. CrossRef Updated Treatment Guidelines for Chronic Hepatitis B
Jihyun An
The Korean Journal of Medicine.2022; 97(6): 353. CrossRef A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab
Xiangjuan Guo, Tongtong Ji, Shengliang Xin, Jinghang Xu, Yanyan Yu
Frontiers in Immunology.2022;[Epub] CrossRef Report on the External Quality Assessment Scheme for Molecular Microbiology, Hepatitis Virus 1, 2 (2016–2021)
Hee-Won Moon, Tae Hwan Lee, Jong Do Seo
Journal of Laboratory Medicine and Quality Assurance.2022; 44(4): 191. CrossRef Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events
Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
Digestive Diseases and Sciences.2021; 66(8): 2816. CrossRef Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus–Related Hepatocellular Carcinoma After Surgical Resection
Jonggi Choi, Chanyoung Jo, Young‐Suk Lim
Hepatology.2021; 73(2): 661. CrossRef Sustained off therapy response after peglyated interferon favours functional cure and no disease progression in chronic hepatitis B
Soon Kyu Lee, Jung Hyun Kwon, Sung Won Lee, Jeong Won Jang, Heechul Nam, Kyoung Won Baik, Sun Hong Yoo, Soon Woo Nam, Pil Soo Sung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Liver International.2021; 41(2): 288. CrossRef Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B
Hye-Lin Kim, Gi-Ae Kim, Jae-A Park, Hye-Rim Kang, Eui-Kyung Lee, Young-Suk Lim
Gut.2021; 70(11): 2172. CrossRef Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B
Hye Won Lee, Young Eun Chon, Beom Kyung Kim, Terry Cheuk-Fung Yip, Yee-Kit Tse, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Sang Hoon Ahn
European Journal of Internal Medicine.2021; 84: 68. CrossRef Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies
Jonggi Choi, Young‐Suk Lim
The Kaohsiung Journal of Medical Sciences.2021; 37(4): 262. CrossRef Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B
Young Eun Ahn, Sang Jun Suh, Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
The Korean Journal of Gastroenterology.2021; 77(1): 22. CrossRef Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
American Journal of Gastroenterology.2021;[Epub] CrossRef Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
Yewan Park, Jeong-Hoon Lee, Dong Hyun Sinn, Jun Yong Park, Minseok Albert Kim, Yoon Jun Kim, Jung-Hwan Yoon, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clinical and Translational Gastroenterology.2021; 12(1): e00290. CrossRef Risk assessment of hepatocellular carcinoma and liver‐related events using ultrasonography and transient elastography in patients with chronic hepatitis B
Sung Hwan Yoo, Tae Seop Lim, Hyun Woong Lee, Ja Kyung Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jung Il Lee, Kwan Sik Lee, Seung Up Kim
Journal of Viral Hepatitis.2021; 28(10): 1362. CrossRef Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
Xinhe Zhang, Lin Guan, Haoyu Tian, Zilu Zeng, Jiayu Chen, Die Huang, Ji Sun, Jiaqi Guo, Huipeng Cui, Yiling Li
Frontiers in Oncology.2021;[Epub] CrossRef The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
Minah Kim, Yeonju Lee, Jun Sik Yoon, Minjong Lee, So Shin Kye, Sun Woong Kim, Yuri Cho
Cancers.2021; 13(10): 2301. CrossRef The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Hepatocellular Carcinoma.2021; Volume 8: 467. CrossRef Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis B
Jeong Eun Song, Jun Yong Park
Expert Opinion on Pharmacotherapy.2021; 22(18): 2427. CrossRef Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B
Yoon Seok Lee, Soo Min Bang, Young-Sun Lee
Journal of Clinical Medicine.2021; 10(11): 2320. CrossRef Nationwide Data on the Characteristics of Linked-to-Care Chronic Hepatitis B in Korea
Young Cheol Ju, Dae Won Jun, Eileen L. Yoon, Sang Bong Ahn, Yun Jin Kim, Mindie H. Nguyen
Journal of Clinical Medicine.2021; 10(20): 4633. CrossRef External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Viral Hepatitis.2021; 28(6): 951. CrossRef Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir
Xiaomo Wang, Yu Chen, Manman Xu, Kailiang Cheng, Xiaoman Duan, Wei Liao, Yanhong Wang, Ying Lu, Zhongping Duan, Li Wang
Expert Review of Gastroenterology & Hepatology.2021; 15(11): 1337. CrossRef Twelve‐month post‐treatment parameters are superior in predicting hepatocellular carcinoma in patients with chronic hepatitis B
Sang Bong Ahn, Jun Choi, Dae Won Jun, Hyunwoo Oh, Eileen L. Yoon, Hyoung Su Kim, Soung Won Jeong, Sung Eun Kim, Jae‐Jun Shim, Yong Kyun Cho, Hyo Young Lee, Sung Won Han, Mindie H. Nguyen
Liver International.2021; 41(7): 1652. CrossRef Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression
Hankil Lee, Beom Kyung Kim, Sungin Jang, Sang Hoon Ahn
Clinical and Translational Gastroenterology.2021; 12(2): e00299. CrossRef Association between HBs Ag quantification and the risk of hepatocellular carcinoma in patients treated with tenofovir disoproxil fumarate or entecavir
Jung Hyun Lim, Jung Hwan Yu, Young Ju Suh, Jin-Woo Lee, Young-Joo Jin
Medicine.2021; 100(39): e27417. CrossRef Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma
Soon Kyu Lee, Pil Soo Sung, Sung-Soo Park, Chang-Ki Min, Heechul Nam, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
Clinical Infectious Diseases.2021; 73(6): e1372. CrossRef Development and Pilot Testing of a Smartphone-Based Self-Care Program for Patients with Chronic Hepatitis B
Yeonsoo Jang, Sang Hoon Ahn, Kyunghwa Lee, Oh Young Kwon, Jeong Hyun Kim
International Journal of Environmental Research and Public Health.2021; 18(21): 11139. CrossRef Overexpressed Proteins in HCC Cell-Derived Exosomes, CCT8, and Cofilin-1 Are Potential Biomarkers for Patients with HCC
Hyo Jung Cho, Geum Ok Baek, Moon Gyeong Yoon, Hye Ri Ahn, Ju A Son, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
Diagnostics.2021; 11(7): 1221. CrossRef Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
Yu-Fen Tsai, Chin-Mu Hsu, Hui-Hua Hsiao
Journal of Personalized Medicine.2021; 11(4): 267. CrossRef Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
Joo Hyun Oh, Hye Won Lee, Dong Hyun Sinn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
Hepatology International.2021; 15(4): 892. CrossRef Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway
Sung Won Lee, Sung Min Kim, Wonhee Hur, Byung-Yoon Kang, Hae Lim Lee, Heechul Nam, Sun Hong Yoo, Pil Soo Sung, Jung Hyun Kwon, Jeong Won Jang, Seong-Jun Kim, Seung Kew Yoon, Partha Mukhopadhyay
PLOS ONE.2021; 16(12): e0261067. CrossRef Reply to “Emergent liver transplantation for patients with acute-on-chronic liver failure”
Ji Eun Kim, Dong Hyun Sinn, Gyu-Seong Choi
Digestive and Liver Disease.2021; 53(10): 1361. CrossRef Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
Cancers.2021; 13(14): 3424. CrossRef Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
Young-Hwan Ahn, Heirim Lee, Do Young Kim, Hye Won Lee, Su Jong Yu, Young Youn Cho, Jeong Won Jang, Byoung Kuk Jang, Chang Wook Kim, Hee Yeon Kim, Hana Park, Hyo Jung Cho, Bumhee Park, Soon Sun Kim, Jae Youn Cheong
Gut and Liver.2021; 15(3): 410. CrossRef Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B
Jihye Lim, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Han Chu Lee, Yeonjung Ha
Cancers.2021; 13(22): 5609. CrossRef Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response
Ji Eun Na, Dong Hyun Sinn, Jeong‐Hoon Lee, Hee Joon Jang, Seon Yeong Baek, Kyung A Kim, Won Seok Kang, Geum‐Youn Gwak, Young‐Han Paik, Yoon Jun Kim, Moon Seok Choi, Jung‐Hwan Yoon, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Journal of Viral Hepatitis.2021; 28(10): 1392. CrossRef Differential Effectiveness of Tenofovir and Entecavir for Prophylaxis of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Depending on Coexisting Cirrhosis and Prior Exposure to Antiviral Therapy
Seogsong Jeong, Yuri Cho, Sang Min Park, Won Kim
Journal of Clinical Gastroenterology.2021; 55(9): e77. CrossRef Improving the Prediction of Relapse After Nucleos(t)ide Analogue Discontinuation in Patients With Chronic Hepatitis B
Do Seon Song, Jeong Won Jang, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clinical Infectious Diseases.2021; 73(4): e892. CrossRef Association of Metabolic Risk Factors With Risks of Cancer and All‐Cause Mortality in Patients With Chronic Hepatitis B
Yun Bin Lee, Hyemi Moon, Jeong‐Hoon Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Fabien Zoulim, Juneyoung Lee, Jung‐Hwan Yoon
Hepatology.2021; 73(6): 2266. CrossRef The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus–related hepatocellular carcinoma
Ji Hyun Lee, Beom Kyung Kim, Soo Young Park, Won Young Tak, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Dong Hyun Sinn, Seung Up Kim
European Journal of Internal Medicine.2021; 89: 48. CrossRef Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
Hepatology International.2021; 15(5): 1083. CrossRef Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123. CrossRef Diagnostic and risk stratification aspects of liver fibrosis progression in chronic hepatitis B and C viral infection
Dmitry V. Garbuzenko
Medical Journal of the Russian Federation.2021; 27(4): 373. CrossRef Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy
Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Hwa Kim, Ha Yan Kim, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo
Clinical Gastroenterology and Hepatology.2020; 18(3): 693. CrossRef Reply to: “Comment on – A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in the Republic of Korea”
Beom Kyung Kim
Journal of Hepatology.2020; 72(1): 198. CrossRef Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy
Chung Gyo Seo, Sun Young Yim, Soon Ho Um, Yoo Ra Lee, Yoo Jin Lee, Tae Hyung Kim, Hyun Gil Goh, Young Sun Lee, Sang Jun Suh, Na Yeon Han, Hyuk Soon Choi, Eun Sun Kim, Bora Keum, Yeon Seok Seo, Hyung Joon Yim, Ji Hoon Kim, Dong Sik Kim, Yoon Tae Jeen, Hoon
Clinics and Research in Hepatology and Gastroenterology.2020; 44(4): 532. CrossRef Kidney disease in patients with chronic liver disease
Jae Hyun Chang
Journal of the Korean Medical Association.2020; 63(1): 14. CrossRef Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
Hyo Cho, Jung Eun, Geum Baek, Chul Seo, Hye Ahn, Soon Kim, Sung Cho, Jae Cheong
Journal of Clinical Medicine.2020; 9(1): 281. CrossRef Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen‐negative, core antibody‐positive recipients
Jihye Kim, Se Jin Chung, Dong Hyun Sinn, Kyo Won Lee, Jae Berm Park, Wooseong Huh, Jung Eun Lee, Hye Ryoun Jang, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Journal of Viral Hepatitis.2020; 27(7): 739. CrossRef Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
Yeon Woo Jung, Moonhyun Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Journal of Korean Medical Science.2020;[Epub] CrossRef Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B
Emilia Hadziyannis, Stephanos Hadziyannis
Expert Review of Gastroenterology & Hepatology.2020; 14(4): 243. CrossRef Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B‐related hepatocellular carcinoma
Jun Sik Yoon, Hyo Young Lee, Sung Won Chung, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Haeryoung Kim, Jung‐Hwan Yoon, Yoon Jun Kim
Journal of Gastroenterology and Hepatology.2020; 35(11): 1960. CrossRef Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients
Gi‐Ae Kim, Seungbong Han, Gwang Hyeon Choi, Jonggi Choi, Young‐Suk Lim
Alimentary Pharmacology & Therapeutics.2020; 51(11): 1169. CrossRef Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance
Hyun Woong Lee, Jung Il Lee, Saein Kim, Sora Kim, Hye Young Chang, Kwan Sik Lee
BMC Gastroenterology.2020;[Epub] CrossRef An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well‐controlled viremia
Hye W. Lee, Soo Y. Park, Myeongjee Lee, Eun J. Lee, Jinae Lee, Seung U. Kim, Jun Y. Park, Do Y. Kim, Sang H. Ahn, Beom K. Kim
Liver International.2020; 40(7): 1736. CrossRef Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg‐positive versus HBeAg‐negative patients. Authors' reply
Gi‐Ae Kim, Young‐Suk Lim
Alimentary Pharmacology & Therapeutics.2020; 51(12): 1440. CrossRef Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase
Han Ah Lee, Hyun Woong Lee, In Hee Kim, Soo Young Park, Dong Hyun Sinn, Jung Hwan Yu, Yeon Seok Seo, Soon Ho Um, Jung Il Lee, Kwan Sik Lee, Chang Hun Lee, Won Young Tak, Young Oh Kweon, Wonseok Kang, Yong‐Han Paik, Jin‐Woo Lee, Sang Jun Suh, Young Kul Jun
Alimentary Pharmacology & Therapeutics.2020; 52(1): 196. CrossRef Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir
Tae Seop Lim, Hyun Woong Lee, Jung Il Lee, In Hee Kim, Chang Hun Lee, Byoung Kuk Jang, Woo Jin Chung, Hyung Joon Yim, Sang Jun Suh, Yeon Seok Seo, Han Ah Lee, Jung Hwan Yu, Jin‐Woo Lee, Sang Gyune Kim, Young Seok Kim, Soo Young Park, Won Young Tak, Soon S
Journal of Viral Hepatitis.2020; 27(10): 1052. CrossRef Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma
Mi Young Jeon, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn, Seung Up Kim
Journal of Viral Hepatitis.2020; 27(9): 932. CrossRef High body mass index hinders fibrosis improvement in patients receiving long‐term tenofovir therapy in hepatitis B virus‐related cirrhosis
Young Eun Chon, Kyu Sik Jung, Yeonjung Ha, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Sang Hoon Ahn, Do Young Kim, Kwang‐Hyub Han, Jun Yong Park
Journal of Viral Hepatitis.2020; 27(11): 1119. CrossRef Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?
Byoung Kuk Jang
Clinical and Molecular Hepatology.2020; 26(3): 312. CrossRef Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial
Hyung Joon Yim, Won Kim, Sang Hoon Ahn, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Young Kul Jung, Soon Ho Um, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Byung Seok Lee, Ju Hyun Kim, Hong Soo Ki
American Journal of Gastroenterology.2020; 115(8): 1217. CrossRef Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B
Kyung Hyun Kim, Dong Jin Joo, Yong-ho Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Digestive and Liver Disease.2020; 52(11): 1338. CrossRef Serum ERK1/2 proteins fluctuating with HBV infection report frequency of viral-specific CD8+ T cells and predict IFNα therapeutic effect in chronic hepatitis B patients
Zhong Fang, Xiaoyu Yu, Shuangmei Tong, Chuan Lu, Yuxian Huang, Liang Chen, Zhenghong Yuan, Yi Zhang
Clinical Immunology.2020; 219: 108570. CrossRef Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang
Scientific Reports.2020;[Epub] CrossRef Editorial: comorbidities in patients with chronic hepatitis B—authors' reply
Eileen L. Yoon, Hyunwoo Oh, Dae Won Jun, Mindie H. Nguyen
Alimentary Pharmacology & Therapeutics.2020; 52(5): 893. CrossRef A multi‐centre study of trends in hepatitis B virus‐related hepatocellular carcinoma risk over time during long‐term entecavir therapy
Seung Up Kim, Yong Eun Chon, Yeon Seok Seo, Hye Won Lee, Han Ah Lee, Mi Na Kim, In Kyung Min, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Beom Kyung Kim, Soo Young Park
Journal of Viral Hepatitis.2020; 27(12): 1352. CrossRef THERAPEUTIC PLASMAPHERESIS IN A COMPLEX TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS
Vladislav V. Lyubchak, Viktoriia M. Plaksa, Ihor M. Pelo, Michael P. Kovalishyn, Viktor P. Lyubchak, Vladimir V. Horokh, Tetyana Iu. Lisovenko, Viktoriia V. Ilyina, Liliya M. Khomenko
Wiadomości Lekarskie.2020; 73(7): 1454. CrossRef Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion Sojung Han, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Dai Hoon Han, Beom Kyung Kim
Journal of Hepatocellular Carcinoma.2020; Volume 7: 403. CrossRef Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen–Negative Patients: An Asian Perspective
Tung‐Hung Su, Jia‐Horng Kao
Clinical Liver Disease.2020; 16(6): 244. CrossRef Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients
Daniel E Dulek, Robert C Fuhlbrigge, Alison C Tribble, James A Connelly, Michele M Loi, Hassan El Chebib, Shanmuganathan Chandrakasan, William R Otto, Caroline Diorio, Garrett Keim, Kelly Walkovich, Preeti Jaggi, Jennifer E Girotto, April Yarbrough, Edwar
Journal of the Pediatric Infectious Diseases Society.2020; 9(6): 716. CrossRef Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
Hye Won Lee, Eun Hwa Kim, Jinae Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
Clinical and Translational Gastroenterology.2020; 11(3): e00140. CrossRef Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study
Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Ju Lee, Hye Jung Shin, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo Young Park
Cancer Epidemiology, Biomarkers & Prevention.2020; 29(4): 832. CrossRef Reply to: “Comparison of risk of hepatocellular carcinoma between tenofovir and entecavir: One direction or no direction”
Beom Kyung Kim
Journal of Hepatology.2019; 71(4): 847. CrossRef New Potential Therapies for Chronic Hepatitis B
Sun Hong Yoo, Jung Hyun Kwon
The Korean Journal of Gastroenterology.2019; 74(5): 267. CrossRef Long Term Efficacy of Antiviral Therapy: Mortality and Incidence of Hepatocellular Carcinoma
Hyun Woong Lee
The Korean Journal of Gastroenterology.2019; 74(5): 251. CrossRef Prophylactic Antiviral Treatment in Immunosuppressed Chronic Hepatitis B Patients
Eileen L. Yoon
The Korean Journal of Gastroenterology.2019; 74(5): 258. CrossRef Natural History and Treatment Indications of Chronic Hepatitis B
Dong Hyun Sinn
The Korean Journal of Gastroenterology.2019; 74(5): 245. CrossRef
|